Plaque Psoriasis Market SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024 - 2031)

Plaque Psoriasis Market is segmented By Treatment (Systemic Therapies, Topical Therapies, Phototherapy), By Severity (Mild Plaque Psoriasis, Moderate Plaque Psoriasis, Severe Plaque Psoriasis), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa). The report offers the value (in USD Billion) for the above-mentioned segments.

Plaque Psoriasis Market is segmented By Treatment (Systemic Therapies, Topical Therapies, Phototherapy), By Severity (Mild Plaque Psoriasis, Moderate ....

Plaque Psoriasis Market Size

Market Size in USD

CAGR6.9%

Study Period	2024 - 2031
Base Year of Estimation	2023
CAGR	6.9%
Market Concentration	High
Major Players	AbbVie Inc., Novartis International AG, Johnson & Johnson (Janssen Pharmaceuticals), Eli Lilly and Company, Amgen Inc.

*Disclaimer: Major players are listed in no particular order.

*Source: Coherent Market Insights

Want to purchase customized report?
please let us know !

Plaque Psoriasis Market Analysis

The plaque psoriasis market is estimated to be valued at USD 30.14 Bn in 2024 and is expected to reach USD 48.1 Bn by 2031, growing at a compound annual growth rate (CAGR) of 6.9% from 2024 to 2031. The plaque psoriasis market has been witnessing rising demand for biologics and biosimilars for the treatment of plaque psoriasis. Furthermore, expiry of patents of blockbuster biologics has led to market entry of biosimilars at more affordable prices than reference biologics, improving access to patients.

Plaque Psoriasis Market Report Snapshots

Buy Now